These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 7181402)

  • 21. Effect of sequential applications of topical tacrolimus and topical corticosteroids in the treatment of pediatric atopic dermatitis: an open-label pilot study.
    Kubota Y; Yoneda K; Nakai K; Katsuura J; Moriue T; Matsuoka Y; Miyamoto I; Ohya Y
    J Am Acad Dermatol; 2009 Feb; 60(2):212-7. PubMed ID: 19027990
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A multicenter, randomized, vehicle-controlled clinical study to examine the efficacy and safety of MAS063DP (Atopiclair) in the management of mild to moderate atopic dermatitis in adults.
    Abramovits W; Boguniewicz M;
    J Drugs Dermatol; 2006 Mar; 5(3):236-44. PubMed ID: 16573256
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Contact dermatitis caused by ascorbyl tetraisopalmitate in a cream used for the management of atopic dermatitis.
    Assier H; Wolkenstein P; Grille C; Chosidow O
    Contact Dermatitis; 2014 Jul; 71(1):60-1. PubMed ID: 24924814
    [No Abstract]   [Full Text] [Related]  

  • 24. Treatment of paediatric atopic dermatitis with pimecrolimus (Elidel, SDZ ASM 981): impact on quality of life and health-related quality of life.
    McKenna SP; Whalley D; de Prost Y; Staab D; Huels J; Paul CF; van Assche D
    J Eur Acad Dermatol Venereol; 2006 Mar; 20(3):248-54. PubMed ID: 16503881
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Methicillin-resistant Staphylococcus aureus colonization in children with atopic dermatitis.
    Suh L; Coffin S; Leckerman KH; Gelfand JM; Honig PJ; Yan AC
    Pediatr Dermatol; 2008; 25(5):528-34. PubMed ID: 18950393
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Review of pimecrolimus cream 1% in children for the treatment of mild to moderate atopic dermatitis.
    Cohen B
    Clin Pediatr (Phila); 2007 Jan; 46(1):7-15. PubMed ID: 17164503
    [No Abstract]   [Full Text] [Related]  

  • 27. [Post-marketing surveillance on treatment of 5,665 patients with atopic dermatitis using the calcineurin inhibitor pimecrolimus: positive effects on major symptoms of atopic dermatitis and on quality of life].
    Sunderkötter C; Weiss JM; Bextermöller R; Löffler H; Schneider D
    J Dtsch Dermatol Ges; 2006 Apr; 4(4):301-6. PubMed ID: 16638059
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Viewpoint of the German Dermatologic Society (DDG) concerning the decision of the American Food and Drug Administration (FDA) on the use of pimecrolimus cream and tacrolimus ointment in the treatment of atopic dermatitis (neurodermatitis)].
    Luger TA; Gollnick H
    J Dtsch Dermatol Ges; 2005 Jun; 3(6):415-6. PubMed ID: 15892843
    [No Abstract]   [Full Text] [Related]  

  • 29. A study of targeted enhanced patient care for pediatric atopic dermatitis (STEP PAD).
    Shaw M; Morrell DS; Goldsmith LA
    Pediatr Dermatol; 2008; 25(1):19-24. PubMed ID: 18304147
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Therapy of atopic eczema with calcineurin inhibitors].
    Luger TA; Bieber T; Meurer M; Mrowietz U; Schwarz T; Simon J; Werfel T; Zuberbier T
    J Dtsch Dermatol Ges; 2005 May; 3(5):385-91. PubMed ID: 16372807
    [No Abstract]   [Full Text] [Related]  

  • 31. Tacrolimus ointment 0.03% shows efficacy and safety in pediatric and adult patients with mild to moderate atopic dermatitis.
    Chapman MS; Schachner LA; Breneman D; Boguniewicz M; Gold MH; Shull T; Linowski GJ; Jaracz E;
    J Am Acad Dermatol; 2005 Aug; 53(2 Suppl 2):S177-85. PubMed ID: 16021173
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Advantan for therapy of atopic dermatitis].
    Beridze LR; Zosidze NR
    Georgian Med News; 2009 Jun; (171):31-3. PubMed ID: 19578209
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetics of tacrolimus following topical application of tacrolimus ointment in adult and pediatric patients with moderate to severe atopic dermatitis.
    Krueger GG; Eichenfield L; Goodman JJ; Krafchik BR; Carlin CS; Pang ML; Croy R; Holum ME; Jaracz E; Sawamoto T; Keirns J
    J Drugs Dermatol; 2007 Feb; 6(2):185-93. PubMed ID: 17373177
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Two randomized, double-blind, placebo-controlled studies of fluticasone propionate lotion 0.05% for the treatment of atopic dermatitis in subjects from 3 months of age.
    Eichenfield LF; Miller BH;
    J Am Acad Dermatol; 2006 Apr; 54(4):715-7. PubMed ID: 16546598
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Atopic dermatitis management with tacrolimus ointment (Protopic).
    Kapp A; Allen BR; Reitamo S
    J Dermatolog Treat; 2003; 14(Suppl 1):5-16. PubMed ID: 14522634
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A randomised, double-blind, vehicle-controlled study to evaluate the efficacy and safety of MAS063D (Atopiclair) in the treatment of mild to moderate atopic dermatitis.
    Belloni G; Pinelli S; Veraldi S
    Eur J Dermatol; 2005; 15(1):31-6. PubMed ID: 15701590
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Onset of action of pimecrolimus cream 1% in the treatment of atopic eczema in infants.
    Kaufmann R; Fölster-Holst R; Höger P; Thaçi D; Löffler H; Staab D; Bräutigam M;
    J Allergy Clin Immunol; 2004 Nov; 114(5):1183-8. PubMed ID: 15536429
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term safety and efficacy of tacrolimus ointment for the treatment of atopic dermatitis in children.
    Remitz A; Harper J; Rustin M; Goldschmidt WF; Palatsi R; van der Valk PG; Sharpe G; Smith CH; Dobozy A; Turjanmaa K;
    Acta Derm Venereol; 2007; 87(1):54-61. PubMed ID: 17225017
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence of respiratory symptoms in children with atopic dermatitis attending pediatric dermatology clinics.
    Salob SP; Atherton DJ
    Pediatrics; 1993 Jan; 91(1):8-12. PubMed ID: 8416509
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Atopic dermatitis in children in the United States, 1997-2004: visit trends, patient and provider characteristics, and prescribing patterns.
    Horii KA; Simon SD; Liu DY; Sharma V
    Pediatrics; 2007 Sep; 120(3):e527-34. PubMed ID: 17766497
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.